Journal of vascular surgery. Venous and lymphatic disorders最新文献

{"title":"The role of venoactive compounds in the treatment of chronic venous disease","authors":"Monika Lecomte Gloviczki MD, PhD ,&nbsp;Stavros K. Kakkos MD, MSc, PhD, RVT ,&nbsp;Tomasz Urbanek MD ,&nbsp;John Chuback MD, FACS ,&nbsp;Andrew Nicolaides DSc, PhD, MS, FRCS, FRCSE","doi":"10.1016/j.jvsv.2025.102258","DOIUrl":"10.1016/j.jvsv.2025.102258","url":null,"abstract":"<div><h3>Background</h3><div>Chronic venous disease (CVD) is a major global health issue, affecting millions of people and contributing to significant morbidity and economic strain. The condition's pathophysiology is complex, involving both mechanical and biochemical processes that lead to venous reflux, obstruction, and chronic inflammation. This review focuses on the role of venoactive compounds (VACs), also known as venoactive drugs in Europe and other parts of the world, in managing CVD. The aim was to review the scientific evidence and to define the role of VACs within the comprehensive treatment algorithm for CVD, alongside established and well adopted interventional therapies and noninterventional therapies such as compression.</div></div><div><h3>Methods</h3><div>The review of the scientific evidence was done on VACs mechanism of action and efficacy in alleviating CVD symptoms, reducing swelling or venous edema, and improving healing of venous leg ulcers. Whenever available, systematic reviews, meta-analyses and randomized controlled trials were used. The quality of evidence assessment followed the GRADE methodology from A (high), B (moderate), to C (low to very low) quality.</div></div><div><h3>Results</h3><div>Venoactive drugs or compounds share similar effects, such as sealing the endothelial barrier, enhancing lymphatic drainage, reducing edema, improving venous tone, inhibiting leukocyte adhesion to vein walls/valves and inflammatory mediator release, lowering blood viscosity, and promoting red blood cell flexibility. Scientific evidence on the VACs effectiveness on CVD symptoms (pain, cramps, and heaviness) and swelling or edema have shown some variability. Micronized purified flavonoid fraction (MPFF) and Ruscus extract combined with hesperidin methyl chalcone and ascorbic acid had the highest, mostly level A, quality of evidence. In venous leg ulcers, micronized purified flavonoid fraction, sulodexide, and pentoxifylline were the most effective adjunctive treatments, with evidence level A.</div></div><div><h3>Conclusions</h3><div>The existing scientific evidence provides a strong rationale for incorporating VACs into a comprehensive treatment plan for CVD, alongside established interventional therapies and noninterventional approaches like compression, to optimize patient outcomes and improve quality of life.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 5","pages":"Article 102258"},"PeriodicalIF":2.8,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144010823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and safety of ovarian vein embolization with N-butyl-2 cyanoacrylate for pelvic venous disorder: Analysis of 100 cases","authors":"Jose María Hipola MD ,&nbsp;Alberto Alonso MD, PhD ,&nbsp;Regina Cárdenas MD ,&nbsp;Eugenia Pillado MD ,&nbsp;Jose Ignacio Leal MD, PhD","doi":"10.1016/j.jvsv.2025.102256","DOIUrl":"10.1016/j.jvsv.2025.102256","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to evaluate the safety and efficacy of ovarian vein embolization using N-butyl-2 cyanoacrylate (NBCA) for treating pelvic venous disorder-associated chronic pelvic pain.</div></div><div><h3>Methods</h3><div>This retrospective study analyzed 100 patients who underwent ovarian vein embolization with NBCA at a single institution between February 2018 and June 2024. Pelvic venous insufficiency was confirmed by duplex ultrasound and abdominal computed tomography or magnetic resonance imaging, and NBCA was the sole embolic agent. Pain levels were assessed pre- and post-procedure using the Visual Analogue Scale (VAS) in three categories: pain on standing, dyspareunia, and menstrual pain. Follow-up included clinical evaluation and VAS scoring at 1 to 3 months and annually. Statistical analysis determined the significance of pain reduction.</div></div><div><h3>Results</h3><div>Technical success was achieved in all cases, with complete occlusion of the target veins. Clinical success was observed in most patients, with significant improvement in VAS scores across all categories (<em>P</em> &lt; .05). Due to symptom recurrence, four patients (4%) required reintervention during follow-up. No NBCA-related complications were reported.</div></div><div><h3>Conclusions</h3><div>In our study, ovarian vein embolization with NBCA appears to be a safe and effective treatment for pelvic venous disorder-associated chronic pelvic pain, providing significant pain relief. Additionally, it offers advantages over permanent metal implants such as the potential for gradual polymer degradation over time and avoiding interference in future imaging studies.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 5","pages":"Article 102256"},"PeriodicalIF":2.8,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144028540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Three-year follow-up of a randomized controlled trial comparing concomitant and staged treatment of varicose veins following mechanochemical ablation of the great saphenous vein","authors":"Tasnuva Rahman BM ,&nbsp;Katariina Noronen MD, PhD ,&nbsp;Sari Vähäaho MD, PhD ,&nbsp;Ivika Heinola MD, PhD ,&nbsp;Maarit Venermo MD, PhD ,&nbsp;Karoliina Halmesmäki MD, PhD","doi":"10.1016/j.jvsv.2025.102255","DOIUrl":"10.1016/j.jvsv.2025.102255","url":null,"abstract":"<div><h3>Objective</h3><div>Mechanochemical ablation is a feasible endovenous nonthermal, nontumescent treatment method for saphenous vein insufficiency. Nevertheless, the ideal approach to managing varicose veins following intervention of the saphenous trunk remains ambiguous. Treatment of varicose veins can be administered either simultaneously or in a staged manner. The aim of this 3-year follow-up study was to present the midterm outcomes of a randomized controlled trial, comparing concomitant and staged treatment of tributaries.</div></div><div><h3>Methods</h3><div>Venous outpatient clinic patients with unilateral Clinical, Etiological, Anatomical, Pathophysiological (CEAP) C2-4 venous disease were enrolled in a randomized controlled trial during 2016 to 2017 at Helsinki University Hospital. After eligibility assessment of 1149 patients, 85 met the inclusion criteria: age of 20 to 70 years, ultrasound-verified refluxing above-knee great saphenous vein with a diameter of 5 to 10 mm, written consent from patients, and not having deep venous reflux, peripheral artery disease, pregnancy, lymphoedema, body mass index &gt;40 kg/m², allergy to the sclerosant, a history of deep vein thrombosis, or any form of coagulopathy. Participants were randomized, in a 1:1 ratio, to receive either staged tributary treatment with foam sclerotherapy at 3 months, if required (Group 1), or concomitant phlebectomies (Group 2), adjunct to mechanochemical ablation of the great saphenous trunk. All patients were invited to attend a 3-year follow-up, during which the initially treated leg was assessed with duplex ultrasound. The primary outcome was reintervention rate during follow-up. Secondary outcomes comprised presence of above-knee great saphenous vein reflux, patient satisfaction, status of the great saphenous vein, number of varicose veins, and symptoms at follow-up.</div></div><div><h3>Results</h3><div>During follow-up, 11.4% (n = 5/44) (95% confidence interval [CI], 0.02-0.21) in Group 1 and 4.9% (n = 2/41) (95% CI, −0.02 to 0.11) in Group 2 was in need of additional treatment (Group 1 vs Group 2, odds ratio [OR], 2.5; 95% CI, 0.46-13.67; <em>P</em> = .435). The treatment groups did not elicit statistically significant variances in above-knee great saphenous vein reflux (<em>P</em> = .603), disease-specific and health-related quality of life (<em>P</em> = .238 and <em>P</em> = .255, respectively), status of the great saphenous vein (<em>P</em> = .112), or symptoms. However, noninferiority analysis suggests the staged approach to be inferior to the concomitant approach. Furthermore, Group 1 exhibited more varicosities at 3 years compared with Group 2, but this did not cause differences in the extent of symptoms or overall patient satisfaction.</div></div><div><h3>Conclusions</h3><div>Staged treatment of tributaries in C2-4 venous disease provides acceptable midterm outcomes compared with simultaneous treatment. However, its potential inferiority shoul","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 5","pages":"Article 102255"},"PeriodicalIF":2.8,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143975099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An artificial intelligence interpretable tool to predict risk of deep vein thrombosis after endovenous thermal ablation","authors":"Azadeh Tabari MD ,&nbsp;Yu Ma PhD ,&nbsp;Jesus Alfonso PhD ,&nbsp;Anthony Gebran MD ,&nbsp;Haytham Kaafarani MD ,&nbsp;Dimitris Bertsimas PhD ,&nbsp;Dania Daye MD, PhD","doi":"10.1016/j.jvsv.2025.102253","DOIUrl":"10.1016/j.jvsv.2025.102253","url":null,"abstract":"<div><h3>Objective</h3><div>Endovenous thermal ablation (EVTA) stands as one of the primary treatments for superficial venous insufficiency. Concern exists about the potential for thromboembolic complications following this procedure. Although rare, those complications can be severe, necessitating early identification of patients prone to increased thrombotic risks. This study aims to leverage artificial intelligence-based algorithms to forecast patients’ likelihood of developing deep vein thrombosis (DVT) within 30 days following EVTA.</div></div><div><h3>Methods</h3><div>From 2007 to 2017, all patients who underwent EVTA were identified using the American College of Surgeons National Surgical Quality Improvement Program database. We developed and validated four machine learning models using demographics, comorbidities, and laboratory values to predict the risk of postoperative DVT: Classification and Regression Trees (CART), Optimal Classification Trees (OCT), Random Forests, and Extreme Gradient Boosting (XGBoost). The models were trained using all the available variables. SHapley Additive exPlanations analysis was adopted to interpret model outcomes and offer medical insights into feature importance and interactions.</div></div><div><h3>Results</h3><div>A total of 21,549 patients were included (mean age, 54 ± 14 years; 67% female). In this cohort, 1.59% developed DVT. The XGBoost model had good discriminative power for predicting DVT risk with area under the curve of 0.711 in the hold-out test set for the all-variable model. Stratification of the test set by age, body mass index, preoperative white blood cell count, and platelet count shows that the model performs equally well across these groups.</div></div><div><h3>Conclusions</h3><div>We developed and validated an interpretable model that enables physicians to predict which patients with superficial venous insufficiency has higher risk of developing DVT within 30 days following EVTA.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 5","pages":"Article 102253"},"PeriodicalIF":2.8,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144063595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Traumatic iliac arteriovenous fistula with giant venous aneurysm following lumbar spine surgery","authors":"Aoi Ogawa BA,&nbsp;Dylan Goto MD,&nbsp;Elna Masuda MD","doi":"10.1016/j.jvsv.2025.102254","DOIUrl":"10.1016/j.jvsv.2025.102254","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 5","pages":"Article 102254"},"PeriodicalIF":2.8,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144021084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparing venous wall effects using the empty vein ablation technique with VELEX catheter, endovenous laser ablation and foam sclerotherapy in an animal model","authors":"Mario Salerno MD ,&nbsp;Daniele Bissacco MD ,&nbsp;Yung-Wei Chi MD ,&nbsp;Sriram Narayanan MD ,&nbsp;Alessandro Addis DVM ,&nbsp;Fabio Martelli MSc, PhD ,&nbsp;Germana Zaccagnini MSc ,&nbsp;Teresa Lucia Aloi MD ,&nbsp;Giovanni Nano MD ,&nbsp;Sergio Gianesini MD, PhD ,&nbsp;Paolo Righini MD","doi":"10.1016/j.jvsv.2025.102251","DOIUrl":"10.1016/j.jvsv.2025.102251","url":null,"abstract":"<div><h3>Objective</h3><div>To describe residual intima and the average media thickness persisted after the empty vein ablation (EVA) technique, endovenous laser ablation (EVLA), and foam sclerotherapy (FS) in a sheep in vivo model.</div></div><div><h3>Methods</h3><div>Six iliofemoral and two jugular sheep vein axes were treated as follows: four with EVA (using polidocanol [POL] 0.5% or 1% with 1 or 3 minutes as contact time), two with FS (FS-1 and FS during Valsalva maneuver [FS-Val], POL1% for 10 minutes), and two with EVLA (1470 nm radial, 80 J/cm²).</div></div><div><h3>Results</h3><div>The average percentage of residual intima layer was 2% (interquartile range [IQR]: 1%-4%) for EVA-POL0.5%-1 minute, 1% (IQR: 0%-3.5%) for EVA-POL0.5%-3 minutes, 2% (IQR: 0%-4%) for EVA-POL1%-1 minute, 0 for EVA-POL1%-3 minutes, 13% (IQR: 13%-15.7%) for FS, 1% (IQR: 0%-3%) for FS-Val, and 1% (IQR: 0%-6%) for EVLA. The average percentage of residual media thickness was 13% (IQR: 8%-15%) for EVA-POL0.5%-1 minute, 6% (IQR: 4%-9%) for EVA-POL0.5%-3 minutes, 13% (IQR: 10%-27%) for EVA-POL1%-1 minute, 6% (IQR: 5%-12%) for EVA-POL1%-3 minutes, 51% (IQR: 40%-62%) for FS, 29% (IQR: 23%-35%) for FS-Val, and 62% (IQR: 41%-75%) for EVLA.</div></div><div><h3>Conclusions</h3><div>EVA demonstrated better results in vein wall damage compared with EVLA and FS, both in intima and media layers.</div></div><div><h3>Clinical Relevance</h3><div>This study provides crucial insights into the effectiveness of different vein treatment techniques, particularly the empty vein ablation method, in minimizing residual intima and media thickness. By evaluating these outcomes in a sheep model, it highlights how empty vein ablation may lead to more vein wall damage compared with endovenous laser ablation and foam sclerotherapy. For clinicians, understanding the comparative efficacy of these treatments is vital for optimizing patient care in managing venous diseases. As the field evolves, these findings could influence clinical decision-making, encouraging the adoption of techniques that promote better long-term outcomes for patients.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 5","pages":"Article 102251"},"PeriodicalIF":2.8,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Optimizing treatment selection in venous malformations through imaging-assisted sequential therapy: a case series analysis","authors":"Weixin Wang MD ,&nbsp;Wei Lu MD ,&nbsp;Chaonan Wang PhD ,&nbsp;Hechen Jia PhD ,&nbsp;Weiwei Chen PhD ,&nbsp;Ye Zhang PhD ,&nbsp;Hui Bi PhD ,&nbsp;Xiaonan Yang MD, PhD","doi":"10.1016/j.jvsv.2025.102250","DOIUrl":"10.1016/j.jvsv.2025.102250","url":null,"abstract":"<div><h3>Objective</h3><div>Venous malformations (VMs) are the most prevalent slow-flow congenital vascular anomalies. Effective management of VMs often necessitates individualized approaches, particularly for lesions with significant interstitial components. This study aims to evaluate a sequential treatment strategy combining sclerotherapy and open surgery, with guidance from ultrasound (US) and magnetic resonance imaging (MRI).</div></div><div><h3>Methods</h3><div>A retrospective analysis was performed on a case series of 10 patients with VMs. Each patient underwent initial sclerotherapy, followed by surgical intervention. Preoperative US and MRI were used to assess treatment progress and optimize the timing of surgery.</div></div><div><h3>Results</h3><div>Sclerotherapy effectively reduced the venous components of VMs by inducing fibrosis, which diminished blood supply and facilitated subsequent surgical excision. Sequential plastic surgical resection successfully removed the interstitial components, further improving outcomes, particularly in cosmetically sensitive areas. Imaging modalities played a key role in monitoring the treatment process; US was effective for superficial lesions, whereas MRI provided essential insights into deeper and more complex malformations.</div></div><div><h3>Conclusions</h3><div>Sequential treatment, incorporating preoperative sclerotherapy and tailored surgical planning, is essential for the effective management of VMs. Further research with larger, multicenter studies is needed to validate these findings and optimize treatment protocols.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 5","pages":"Article 102250"},"PeriodicalIF":2.8,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144028660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Wound-healing and onboard care during long-duration human deep space exploration from a surgical perspective through the lens of a scoping review","authors":"Dora Babocs MD ,&nbsp;Krishi Korrapati BA ,&nbsp;Cooper Lytle BA ,&nbsp;Monika L. Gloviczki MD, PhD ,&nbsp;Gustavo S. Oderich MD ,&nbsp;M. Mark Melin MD ,&nbsp;Rowena Christiansen MD","doi":"10.1016/j.jvsv.2025.102249","DOIUrl":"10.1016/j.jvsv.2025.102249","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to develop a bridge between the fields of aerospace medicine and vascular surgery, and to emphasize the need for leading experts in vascular medicine, interventional radiology, and surgery to address the critical human spaceflight research gaps highlighted by the National Aeronautics and Space Administration (NASA).</div></div><div><h3>Methods</h3><div>A scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted on literature published between 2000 and 2024. A well-defined search strategy was employed for keyword searches across multiple databases, including PubMed, Scopus, Cochrane, Embase, the NASA Life Science Data Archive, NASA technical reports, and Google Scholar.</div></div><div><h3>Results</h3><div>Our review identified 125 relevant studies. These included 30 studies on general health conditions in space and wound healing, 38 addressing risk factors associated with the space environment, and 57 studies examining prevention and treatment options. These findings address NASA’s identified gaps in wound care capabilities (ExMC 4.07), contribute to defining the potential list of medical conditions that could arise during deep-space missions (ExMC 4.24, Med07, Med12, Medical-101), and serve as a milestone for developing integrated exploration medical system models for missions to the Moon and Mars (Medical-501).</div></div><div><h3>Conclusions</h3><div>Many of the identified NASA knowledge gaps—some of which have even been marked as closed due to a lack of research in the field—cannot be effectively addressed without bridging aerospace medicine with related disciplines, such as vascular surgery and chronic wound care.</div></div>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 5","pages":"Article 102249"},"PeriodicalIF":2.8,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144027301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Events of Interest","authors":"","doi":"10.1016/S2213-333X(25)00060-5","DOIUrl":"10.1016/S2213-333X(25)00060-5","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 3","pages":"Article 102225"},"PeriodicalIF":2.8,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"To bleed or not to bleed: Observing risk of concomitant nonsteroidal anti-inflammatory drug and oral anticoagulant use after venous thromboembolism","authors":"J.Blake Iceton MD,&nbsp;Eri Fukaya MD, PhD","doi":"10.1016/j.jvsv.2025.102206","DOIUrl":"10.1016/j.jvsv.2025.102206","url":null,"abstract":"","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":"13 3","pages":"Article 102206"},"PeriodicalIF":2.8,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143806835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}